J&J Tells Okla. Judge It Obeyed FDA When Selling Fentanyl
Johnson & Johnson's subsidiary Janssen followed the FDA's guidance when promoting its fentanyl patch Duragesic and opioid painkiller Nucynta, including stopping marketing that touted low abuse rates for Duragesic, the company's...To view the full article, register now.
Already a subscriber? Click here to view full article